Workflow
Therapies for neuromuscular diseases
icon
搜索文档
Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger
Yahoo Finance· 2025-10-28 17:24
We recently published 10 Big Names Crushing Wall Street. Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the top-performing stocks on Monday. Dyne Therapeutics soared by 41.18 percent on Monday to close at $24.17 apiece following a comment from investment firm Jefferies that it would likewise benefit from Novartis’ $12 billion planned acquisition of its peer, Avidity Biosciences. In a statement over the weekend, Novartis announced that it would acquire shares of Avidity at a price of $72 apiece, represent ...